Story perspectives

Australia Reassesses Medicinal Cannabis Amid Rising Prescriptions

3/18/2026

Summary

Story summary

Australia is reviewing the regulation of medicinal cannabis due to increasing prescriptions of unapproved products.
Experts, including Associate Professor Kotsirilos, stress that medicinal cannabis should be a last-resort treatment when other options fail.
RACGP President Dr. Michael Wright highlighted the limited clinical indications for its use.
The Therapeutic Goods Administration reports that anxiety is a primary reason for prescribing high-potency THC products.
This study aims to inform health practitioners on appropriate prescribing practices.

1 of 1

Story summary

Australia is reviewing the regulation of medicinal cannabis due to increasing prescriptions of unapproved products.
Experts, including Associate Professor Kotsirilos, stress that medicinal cannabis should be a last-resort treatment when other options fail.
RACGP President Dr. Michael Wright highlighted the limited clinical indications for its use.
The Therapeutic Goods Administration reports that anxiety is a primary reason for prescribing high-potency THC products.
This study aims to inform health practitioners on appropriate prescribing practices.